Decitabine in Treating Patients With Advanced Solid Tumors

NCT00030615 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Male Breast Cancer
Recurrent Bladder Cancer
Recurrent Breast Cancer
Recurrent Melanoma
Stage III Melanoma
Stage IV Bladder Cancer
Stage IV Breast Cancer
Stage IV Melanoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: decitabine
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)